Tyrosine kinase inhibitors: the role of pharmacokinetics and pharmacogenetics

被引：3
|
作者：
Sarah, Allegra [1 ,2 ]
Dondi, Emma [1 ]
De Francia, Silvia [1 ]
机构：
[1] Univ Turin, S Luigi Gonzaga Hosp, Dept Clin & Biol Sci, Orbassano, TO, Italy
[2] Univ Turin, San Luigi Gonzaga Hosp, Dept Clin & Biol Sci, Clin Pharmacol Serv Franco Ghezzo, Reg Gonzole 10, I-10043 Turin, TO, Italy
来源：
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | 2023年 / 19卷 / 11期
关键词：
Chemotherapy; Cancer; Precision Medicine; Personalized Treatment; IMATINIB;
D O I：
10.1080/17425255.2023.2277758
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：733 / 739
页数：7
相关论文
共 50 条
  • [1] Clinical pharmacokinetics of tyrosine kinase inhibitors
    van Erp, Nielka P.
    Gelderblom, Hans
    Guchelaar, Henk-Jan
    CANCER TREATMENT REVIEWS, 2009, 35 (08) : 692 - 706
  • [2] Pharmacogenetics of tyrosine kinase inhibitors in gastrointestinal stromal tumor and chronic myeloid leukemia
    Ravegnini, Gloria
    Sammarini, Giulia
    Angelini, Sabrina
    Hrelia, Patrizia
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (07) : 733 - 742
  • [3] Pharmacogenetics of small-molecule tyrosine kinase inhibitors: Optimizing the magic bullet
    Pander, Jan
    Guchelaar, Henk-Jan
    Gelderblom, Hans
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2010, 12 (06) : 654 - 661
  • [4] Role of Tyrosine Kinase Inhibitors in Lung Cancer
    Ansari, J.
    Palmer, D. H.
    Rea, D. W.
    Hussain, S. A.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (05) : 569 - 575
  • [5] The role of tyrosine kinase inhibitors in tuberous sclerosis
    Koluman, Basak
    Yegin, Zeynep Arzu
    Yagci, Muenci
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 147 (01) : 152 - 153
  • [6] Role of tyrosine kinase inhibitors in cancer therapy
    Arora, A
    Scholar, EM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03): : 971 - 979
  • [7] Role of tyrosine kinase inhibitors in tumor immunology
    Nishioka, Yasuhiko
    Aono, Yoshinori
    Sone, Saburo
    IMMUNOTHERAPY, 2011, 3 (01) : 107 - 116
  • [8] The Role of Organic Cation Transporters in the Pharmacokinetics, Pharmacodynamics and Drug-Drug Interactions of Tyrosine Kinase Inhibitors
    Xiu, Fangrui
    Rausch, Magdalena
    Gai, Zhibo
    Su, Shanshan
    Wang, Shijun
    Visentin, Michele
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [9] Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors Focus on Pyrimidines, Pyridines and Pyrroles
    Di Gion, Paola
    Kanefendt, Friederike
    Lindauer, Andreas
    Scheffler, Matthias
    Doroshyenko, Oxana
    Fuhr, Uwe
    Wolf, Juergen
    Jaehde, Ulrich
    CLINICAL PHARMACOKINETICS, 2011, 50 (09) : 551 - 603
  • [10] Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors Focus on 4-Anilinoquinazolines
    Scheffler, Matthias
    Di Gion, Paola
    Doroshyenko, Oxana
    Wolf, Juergen
    Fuhr, Uwe
    CLINICAL PHARMACOKINETICS, 2011, 50 (06) : 371 - 403
12345